Trial Profile
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 28 Nov 2018 Status changed from recruiting to completed.
- 19 May 2016 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 19 May 2016 Status changed from not yet recruiting to recruiting.